Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden · Delayed Price · Currency is SEK 0.1790
-0.0040 (-2.19%)
Aug 6, 2025, 5:15 PM CET
STO:LPGO Revenue
Lipigon Pharmaceuticals AB had revenue of 10.29M SEK in the twelve months ending March 31, 2025, down -37.30% year-over-year. In the year 2024, Lipigon Pharmaceuticals AB had annual revenue of 10.29M, down -37.30%.
Revenue (ttm)
10.29M
Revenue Growth
-37.30%
P/S Ratio
2.64
Revenue / Employee
1.47M
Employees
7
Market Cap
27.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.29M | -6.12M | -37.30% |
| Dec 31, 2023 | 16.41M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 2.21M | -1.80M | -44.86% |
| Dec 31, 2020 | 4.01M | 2.27M | 130.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.31B |
| Getinge AB | 35.50B |
| Medicover AB | 25.22B |
| Camurus AB | 2.27B |
| Asker Healthcare Group AB | 15.88B |
| Bonesupport Holding AB | 1.06B |
| AddLife AB | 10.44B |